Deutsche Bank
TSHA icon

Deutsche Bank’s Taysha Gene Therapies TSHA Stock Holding History

Deutsche Bank’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.21M Buy
247,956
+4,577
+2% +$26.4K ﹤0.01% 2080
2026
Q2 		$1.66M Buy
243,379
+61,610
+34% +$365K ﹤0.01% 2010
2026
Q1 		$813K Buy
181,769
+20,990
+13% +$97.6K ﹤0.01% 2301
2025
Q4 		$884K Buy
160,779
+37,980
+31% +$184K ﹤0.01% 2250
2025
Q3 		$402K Buy
122,799
+15,083
+14% +$42.7K ﹤0.01% 2668
2025
Q2 		$249K Sell
107,716
-26,702
-20% -$58K ﹤0.01% 2845
2025
Q1 		$187K Sell
134,418
-16,665
-11% -$27.9K ﹤0.01% 2980
2024
Q4 		$261K Sell
151,083
-2,409,201
-94% -$5M ﹤0.01% 2979
2024
Q3 		$5.15M Buy
2,560,284
+22,936
+0.9% +$50.3K ﹤0.01% 1272
2024
Q2 		$5.68M Buy
+2,537,348
New +$7.38M ﹤0.01% 1199
2022
Q2 		– Sell
-12,366
Closed -$81K – 4325
2022
Q1 		$81K Sell
12,366
-1,458
-11% -$10.9K ﹤0.01% 3654
2021
Q4 		$161K Buy
13,824
+716
+5% +$10.8K ﹤0.01% 3479
2021
Q3 		$244K Sell
13,108
-414
-3% -$7.87K ﹤0.01% 3464
2021
Q2 		$286K Buy
13,522
+7,670
+131% +$177K ﹤0.01% 3574
2021
Q1 		$119K Sell
5,852
-237
-4% -$6.42K ﹤0.01% 3884
2020
Q4 		$162K Buy
+6,089
New +$131K ﹤0.01% 3585

Other funds holding TSHA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Quantum Private Wealth
Quantum Private Wealth Tampa, Florida $391M AUM 50.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Privium Fund Management
Privium Fund Management Amsterdam, Netherlands $516M AUM 18.66% 1-Year Est. Return
Chicago Partners Investment Group
Chicago Partners Investment Group Chicago, Illinois $5.45B AUM 19.52% 1-Year Est. Return

Deutsche Bank's TSHA Position: Q3 2026 in Review

Deutsche Bank increased its Taysha Gene Therapies (TSHA) stake by 1.9% in Q3 2026, buying an estimated $26.4K and bringing the position to 247,956 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2080.

Deutsche Bank first reported a position in TSHA in Q4 2020 and has held it in 16 quarters since. The position peaked at $5.68M in Q2 2024. 64 funds tracked by Wall St. Rank hold TSHA as of Q3 2026.

  • Deutsche Bank held 247,956 shares of Taysha Gene Therapies worth $1.21M as of Q3 2026.
  • Deutsche Bank bought 4,577 Taysha Gene Therapies shares in Q3 2026, an estimated $26.4K.
  • Taysha Gene Therapies made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2080 holding.
  • Deutsche Bank first reported a position in Taysha Gene Therapies in Q4 2020 and has held it in 16 quarters since.
  • Deutsche Bank's Taysha Gene Therapies position peaked at $5.68M in Q2 2024.
  • 64 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.